Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 10 February

Bell Direct
February 10, 2025

Weekly Wrap 7 February

Bell Direct
February 7, 2025

Morning Bell 6 February

Bell Direct
February 6, 2025

Morning Bell 5 February

Bell Direct
February 5, 2025

Morning Bell 4 February

Bell Direct
February 4, 2025

Morning Bell 3 February

Bell Direct
February 3, 2025

Weekly Wrap 31 January

Bell Direct
January 31, 2025

Morning Bell 30 January

Bell Direct
January 30, 2025

Macro Insights: CPI falls in December Qr

Bell Direct
January 29, 2025

Morning Bell 29 January

Bell Direct
January 29, 2025

Morning Bell 28 January

Bell Direct
January 28, 2025